Your briefing

JOHN YOO: Trump scores historic win as Supreme Court reins in lower courts' overreach
The Supreme Court's 6-3 decision in Trump v. Casa limits federal judges' power to issue nationwide injunctions, allowing presidents to advance their c...
Headlines 2 weeks ago
JOHN YOO: Trump scores historic win as Supreme Court reins in lower courts' overreach
Full Coverage

Key blue state Republican says Senate's local tax write-off offer is a 'good deal'
New York Rep. Mike Lawler told Fox News Digital that he is pleased with the Senate's latest compromise on state and local tax deductions.
Headlines 2 weeks ago
Key blue state Republican says Senate's local tax write-off offer is a 'good deal'
Full Coverage

Ancient city possibly ruled by females over 9,000 years ago, researchers say
Science 2 weeks ago
Ancient city possibly ruled by females over 9,000 years ago, researchers say
Full Coverage

Israeli attacks on southern Lebanon kill three people
World 2 weeks ago
Israeli attacks on southern Lebanon kill three people
Full Coverage

Trending

1. Joann's closing
2. Texas Tech basketball
3. UNC basketball
4. Monster Hunter Wilds
5. Ketamine
6. Macron
7. UPMC Memorial shooting
8. Eagles
9. Hims stock
10. Joel Embiid

Popular News

BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
2 weeks ago
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulation und Behandlung von Typ-2-Diabetes sowie präklinische Daten für ein neues Amylin-Analogon bei den 85 Wissenschaftlichen Sitzungen der American Diabetes Association

The mortgage market hopes for rate cuts amid war moves
3 weeks ago
The mortgage market hopes for rate cuts amid war moves

Ukraine returns bodies of 3 Russian soldiers repatriated as ...
3 weeks ago
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry says

BrightGene presenteert positieve fase 2 gegevens voor de dua...
2 weeks ago
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbeheersing en type 2 diabetes, en preklinische gegevens voor een nieuw amylin-analoog tijdens de 85e wetenschappelijke sessies van de American Diabetes Association

BrightGene présente des données positives de phase 2 pour so...
2 weeks ago
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la gestion du poids et le diabète de type 2, ainsi que des données précliniques pour un nouvel analogue de l'amylin, lors de la 85 e édition des Sessions Scientifiques de l'American Diabetes Association
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved